IMAX Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

IMAX heeft een totaal eigen vermogen van $367.8M en een totale schuld van $276.3M, wat de schuld-eigenvermogensverhouding op 75.1% brengt. De totale activa en totale passiva bedragen respectievelijk $847.6M en $479.8M. De EBIT IMAX is $41.3M waardoor de rentedekking 7 is. Het heeft contanten en kortetermijnbeleggingen van $104.5M.

Belangrijke informatie

75.1%

Verhouding schuld/eigen vermogen

US$276.28m

Schuld

Rente dekkingsratio	7x
Contant	US$104.50m
Aandelen	US$367.79m
Totaal verplichtingen	US$479.78m
Totaal activa	US$847.56m

Recente financiële gezondheidsupdates

Recent updates

IMAX Corporation: Overseas Growth Opportunities

Dec 24

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

Dec 10

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Nov 23

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

Nov 07

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Oct 31

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

Oct 13

IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential

Oct 10

When Should You Buy IMAX Corporation (NYSE:IMAX)?

Sep 30

Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

Aug 23

IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings

Jul 30

Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

Jul 26

Is IMAX (NYSE:IMAX) A Risky Investment?

Jun 19

Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

May 22

IMAX Corporation: Good Reasons To Be Bullish

Apr 08

IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 01

When Should You Buy IMAX Corporation (NYSE:IMAX)?

Feb 15

IMAX Corporation: Bull Case Has Merits, But I Am Not Interested

Jan 22

IMAX Corporation: International Expansion Remains A Bright Spot

Nov 19

Some Investors May Be Worried About IMAX's (NYSE:IMAX) Returns On Capital

Oct 13

IMAX Appears Expensive After Post-Pandemic Appreciation

Oct 09

IMAX Corporation Stock: Bullish Following A Blockbuster Summer

Aug 24

Should You Think About Buying IMAX Corporation (NYSE:IMAX) Now?

Jul 31

These Return Metrics Don't Make IMAX (NYSE:IMAX) Look Too Strong

Jul 14

IMAX Corporation: Coming Back To Life

Jun 15

Are Investors Undervaluing IMAX Corporation (NYSE:IMAX) By 31%?

Jun 07

Is It Time To Consider Buying IMAX Corporation (NYSE:IMAX)?

Apr 03

IMAX (NYSE:IMAX) Is Carrying A Fair Bit Of Debt

Mar 13

IMAX Non-GAAP EPS of $0.19 misses by $0.03, revenue of $98M beats by $1.77M

Feb 22

IMAX, Cinema XXI expand relationship with deal for ten new theatres in Indonesia

Feb 14

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

Feb 06

IMAX Corporation: All Eyes On China

Jan 30

IMAX plans to add seven new locations in Japanese expansion

Jan 19

IMAX China gets new key person

Dec 12

Is IMAX (NYSE:IMAX) A Risky Investment?

Nov 28

IMAX, AMC partner on six new Saudi Arabia theaters

Oct 27

Capital Allocation Trends At IMAX (NYSE:IMAX) Aren't Ideal

Oct 17

IMAX Corporation: Watch Recent Buyback Program Expansion And Acquisition

Oct 04

IMAX acquires streaming technology firm SSIMWAVE in cash-and-stock deal

Sep 22

IMAX doubles buyback plan to $400M

Sep 07

Cineworld, IMAX enter expanded deal for upgraded and new locations

Aug 03

Is IMAX (NYSE:IMAX) Using Too Much Debt?

Jul 28

IMAX Is Recovering, Not Growing

Jul 21

IMAX extends current share repurchase program

Jun 30

IMAX (NYSE:IMAX) Will Be Looking To Turn Around Its Returns

Jun 27

IMAX Corporation: Multiple Tailwinds

Jun 21

Does IMAX (NYSE:IMAX) Have A Healthy Balance Sheet?

Mar 29

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $405.8M ) IMAX } overtreffen de korte termijn passiva ( $122.5M ).

Langlopende schulden: De kortetermijnactiva IMAX ( $405.8M ) overtreffen de langetermijnschulden ( $357.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 46.7% ) IMAX wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van IMAX is de afgelopen 5 jaar gestegen van 2.9% naar 75.1%.

Schuldendekking: De schuld van IMAX wordt goed gedekt door de operationele kasstroom ( 22.9% ).

Rentedekking: De rentebetalingen op de schuld van IMAX worden goed gedekt door EBIT ( 7 x dekking).

Balans

Ontdek gezonde bedrijven

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2024/12/30 11:15
Aandelenkoers aan het einde van de dag	2024/12/27 00:00
Inkomsten	2024/09/30
Jaarlijkse inkomsten	2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

IMAX Corporation wordt gevolgd door 29 analisten. 11 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Marla Backer	Ascendiant Capital Markets LLC
James Goss	Barrington Research Associates, Inc.
Michael Hickey	Benchmark Company

IMAX Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

Is IMAX (NYSE:IMAX) A Risky Investment?

IMAX (NYSE:IMAX) Is Carrying A Fair Bit Of Debt

Is IMAX (NYSE:IMAX) A Risky Investment?

Is IMAX (NYSE:IMAX) Using Too Much Debt?

Does IMAX (NYSE:IMAX) Have A Healthy Balance Sheet?

Recent updates

IMAX Corporation: Overseas Growth Opportunities

President of IMAX Global Theatres notifies of intention to sell stock

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

IMAX Corporation (NYSE:IMAX) Shares Could Be 44% Below Their Intrinsic Value Estimate

After Leaping 26% IMAX Corporation (NYSE:IMAX) Shares Are Not Flying Under The Radar

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 22%, revenue downgraded

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Here's Why IMAX (NYSE:IMAX) Can Manage Its Debt Responsibly

IMAX Corporation to Report Q3, 2024 Results on Oct 30, 2024

If EPS Growth Is Important To You, IMAX (NYSE:IMAX) Presents An Opportunity

IMAX Corporation Names Jonathan Fischer as Chief Content Officer

IMAX Corporation: Undervalued Relative To Revenue Growth And Margin Expansion Potential

When Should You Buy IMAX Corporation (NYSE:IMAX)?

Returns On Capital At IMAX (NYSE:IMAX) Paint A Concerning Picture

Consensus EPS estimates increase by 20%

IMAX Corporation: Upbeat Mid-Term Outlook After Great Q2 Signings

Price target increased by 8.0% to US$24.36

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Pinning Down IMAX Corporation's (NYSE:IMAX) P/S Is Difficult Right Now

IMAX Corporation to Report Q2, 2024 Results on Jul 25, 2024

Is IMAX (NYSE:IMAX) A Risky Investment?

Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?

Consensus EPS estimates increase by 13%

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

IMAX Corporation to Report Q1, 2024 Results on Apr 25, 2024

IMAX Corporation: Good Reasons To Be Bullish

Chief Legal Officer & Senior EVP recently sold US$422k worth of stock

IMAX Corporation, Annual General Meeting, Jun 06, 2024

President of IMAX Theatres exercised options and sold US$357k worth of stock

IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

IMAX Corporation Provides Revenue Guidance for the Fiscal Year 2025

Full year 2023 earnings: EPS exceeds analyst expectations

When Should You Buy IMAX Corporation (NYSE:IMAX)?

IMAX Corporation to Report Q4, 2023 Results on Feb 27, 2024

IMAX Corporation: Bull Case Has Merits, But I Am Not Interested

IMAX Corporation Appoints Anne Globe as Chief Marketing Officer

CEO & Director exercised options and sold US$1.4m worth of stock

IMAX Corporation: International Expansion Remains A Bright Spot

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Some Investors May Be Worried About IMAX's (NYSE:IMAX) Returns On Capital

IMAX Corporation to Report Q3, 2023 Results on Oct 25, 2023

IMAX Appears Expensive After Post-Pandemic Appreciation

IMAX Corporation Stock: Bullish Following A Blockbuster Summer

Should You Think About Buying IMAX Corporation (NYSE:IMAX) Now?

These Return Metrics Don't Make IMAX (NYSE:IMAX) Look Too Strong

IMAX Corporation: Coming Back To Life

Are Investors Undervaluing IMAX Corporation (NYSE:IMAX) By 31%?

CEO & Director recently sold US$2.1m worth of stock

Price target increased by 7.1% to US$23.36

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is It Time To Consider Buying IMAX Corporation (NYSE:IMAX)?

IMAX (NYSE:IMAX) Is Carrying A Fair Bit Of Debt

President of IMAX Theatres recently sold US$367k worth of stock

Price target increased by 7.4% to US$21.09

Full year 2022 earnings released: US$0.40 loss per share (vs US$0.38 loss in FY 2021)

Price target increased by 7.0% to US$20.82

IMAX Non-GAAP EPS of $0.19 misses by $0.03, revenue of $98M beats by $1.77M

IMAX, Cinema XXI expand relationship with deal for ten new theatres in Indonesia

IMAX Corporation to Report Q4, 2022 Results on Feb 22, 2023

IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively

IMAX Corporation: All Eyes On China

IMAX plans to add seven new locations in Japanese expansion

CEO & Director exercised options and sold US$1.3m worth of stock

IMAX Corporation Names Daniel Manwaring as Chief Executive Officer

IMAX China gets new key person

IMAX Corporation Announces Executive Changes

President of IMAX Theatres exercised options and sold US$126k worth of stock

Insider recently sold US$104k worth of stock